Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology S. Khelaifia, M. Drancourt Clinical Microbiology and Infection Volume 18, Issue 9, Pages 841-848 (September 2012) DOI: 10.1111/j.1469-0691.2012.03913.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Mode of action of antimicrobial agents against archaea. , Anti-archaeal activity observed. No anti-archaeal activity observed. PAB, p-aminobenzoic acid. Clinical Microbiology and Infection 2012 18, 841-848DOI: (10.1111/j.1469-0691.2012.03913.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 2 Electronmicrographs showing the morphological effects of squalamine on the Methanobrevibacter smithii cell wall, (a) M. smithii without squalamine. (b) M smithii + l µg/mL squalamine. (c) M. smithii after 12 h of incubation in a culture medium containing l µg/mL squalamine. Clinical Microbiology and Infection 2012 18, 841-848DOI: (10.1111/j.1469-0691.2012.03913.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions